Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;41:1380-1385
Published online before print April 28, 2003, doi: 10.1161/01.HYP.0000071317.98004.B3
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/6/1380    most recent
01.HYP.0000071317.98004.B3v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, J. H.
Right arrow Articles by Kim, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, J. H.
Right arrow Articles by Kim, S. H.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology

(Hypertension. 2003;41:1380.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Decreases in ANP Secretion by Lysophosphatidylcholine Through Protein Kinase C

Jeong Hee Han; Chunhua Cao; Sung Zoo Kim; Kyung Woo Cho; Suhn Hee Kim

From the Department of Physiology, Institute for Medical Sciences, Chonbuk National University Medical School, Jeonju, Korea.

Correspondence to Suhn Hee Kim, MD, PhD, 2-20 Keum-Am-Dong-San, Department of Physiology, Chonbuk National University Medical School, Jeonju 561-180, Korea. E-mail shkim{at}moak.chonbuk.ac.kr

Lysophosphatidylcholine (LPC) is an endogenous phospholipid released from the cell membrane during ischemia, and it has potent, local effects on cardiac tissues. LPC has been implicated in arrhythmogenesis during ischemia by increasing intracellular Ca2+. However, it is not known whether LPC influences atrial release of atrial natriuretic peptide (ANP). The aim of this study was to investigate the effect of LPC on ANP secretion from isolated, perfused, beating rat atria. LPC (10 and 30 µmol/L) caused decreases in ANP secretion in a dose-dependent manner, with slight increases in intra-atrial pressure and extracellular fluid (ECF) translocation. Therefore, the ANP secretion in terms of ECF translocation was markedly decreased by LPC. The order of the suppressive effect of ANP release was stearoyl-LPC>LPC>myristoyl-LPC=lauroyl-LPC. Staurosporine and wortmannin significantly attenuated suppression of the ANP release and an increase in intra-atrial pressure by LPC. High extracellular Mg2+ also attenuated the LPC-induced suppression of ANP release. However, other protein kinase C inhibitors such as chelerythrine, GF 109203X, and tamoxifen citrate did not affect LPC-induced suppression of ANP release. In single atrial myocytes, LPC caused increases in intracellular Ca2+ in a dose-dependent manner. The order of an increase in intracellular Ca2+ by LPC was stearoyl-LPC>LPC>myristoyl-LPC=lauroyl-LPC. An increase in intracellular Ca2+ by LPC was attenuated by staurosporine. These results suggest that LPC-induced suppression of ANP release through protein kinase C/Ca2+ and phosphoinositol-3-kinase might in part play an important role in the development of hypertension.


Key Words: atrial natriuretic factor • phospholipases • extracellular space • calcium • protein kinases • heart




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
H.-F. Bao, Z.-R. Zhang, Y.-Y. Liang, J. J. Ma, D. C. Eaton, and H.-P. Ma
Ceramide mediates inhibition of the renal epithelial sodium channel by tumor necrosis factor-{alpha} through protein kinase C
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1178 - F1186.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Yuan, C. Cao, J. H. Han, S. Z. Kim, and S. H. Kim
Adenosine-Stimulated Atrial Natriuretic Peptide Release Through A1 Receptor Subtype
Hypertension, December 1, 2005; 46(6): 1381 - 1387.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Cao, C. W. Kang, S. Z. Kim, and S. H. Kim
Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H150 - H156.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. H. Han, C. Cao, S. M. Kim, F. L. Piao, and S. H. Kim
Attenuation of Lysophosphatidylcholine-Induced Suppression of ANP Release From Hypertrophied Atria
Hypertension, February 1, 2004; 43(2): 243 - 248.
[Abstract] [Full Text] [PDF]